HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Circulating tumour necrosis factor is highly correlated with brainstem serotonin transporter availability in humans.

Abstract
Preclinical studies demonstrate that pro-inflammatory cytokines increase serotonin transporter availability and function, leading to depressive symptoms in rodent models. Herein we investigate associations between circulating inflammatory markers and brainstem serotonin transporter (5-HTT) availability in humans. We hypothesised that higher circulating inflammatory cytokine concentrations, particularly of tumour necrosis factor (TNF-α), would be associated with greater 5-HTT availability, and that TNF-α inhibition with etanercept (sTNFR:Fc) would in turn reduce 5-HTT availability. In 13 neurologically healthy adult women, plasma TNF-α correlated significantly with 5-HTT availability (rho=0.6; p=0.03) determined by [(123)I]-beta-CIT SPECT scanning. This association was replicated in an independent sample of 12 patients with psoriasis/psoriatic arthritis (rho=0.76; p=0.003). Indirect effects analysis, showed that there was a significant overlap in the variance explained by 5-HTT availability and TNF-α concentrations on BDI scores. Treatment with etanercept for 6-8weeks was associated with a significant reduction in 5-HTT availability (Z=2.09; p=0.03; r=0.6) consistent with a functional link. Our findings confirm an association between TNF-α and 5-HTT in both the basal physiological and pathological condition. Modulation of both TNF-α and 5-HTT by etanercept indicate the presence of a mechanistic pathway whereby circulating inflammatory cytokines are related to central nervous system substrates underlying major depression.
AuthorsRajeev Krishnadas, Alice Nicol, Jen Sassarini, Navesh Puri, A David Burden, Joyce Leman, Emilie Combet, Sally Pimlott, Donald Hadley, Iain B McInnes, Jonathan Cavanagh
JournalBrain, behavior, and immunity (Brain Behav Immun) Vol. 51 Pg. 29-38 (Jan 2016) ISSN: 1090-2139 [Electronic] Netherlands
PMID26255693 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins
  • Tumor Necrosis Factor-alpha
  • Etanercept
Topics
  • Arthritis, Psoriatic (diagnostic imaging, metabolism)
  • Brain Stem (diagnostic imaging, metabolism)
  • Depression (metabolism)
  • Etanercept (administration & dosage)
  • Female
  • Humans
  • Middle Aged
  • Serotonin Plasma Membrane Transport Proteins (metabolism)
  • Tomography, Emission-Computed, Single-Photon
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors, blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: